SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-24-068189
Filing Date
2024-03-14
Accepted
2024-03-14 19:25:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d765679dsc13g.htm SC 13G 42770
  Complete submission text file 0001193125-24-068189.txt   44399
Mailing Address 19-48, YOSHINO, MATSUMOTO-CITY NAGANO-PREFECTURE M0 399-8710
Business Address 19-48, YOSHINO, MATSUMOTO-CITY NAGANO-PREFECTURE M0 399-8710 81-3-3279-2307
Kissei Pharmaceutical Co., Ltd. (Filed by) CIK: 0001532923 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13G

Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Subject) CIK: 0001991792 (see all company filings)

IRS No.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94327 | Film No.: 24751986
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)